Phase II clinical trial

Hong Kong, Shanghai & Florham Park, New Jersey – August 28, 2026 HUTCHMED announced that China’s National Medical Products...

FRANKLIN, Tenn., August 18, 2026 Lynch Regenerative Medicine (LRM) announced the completion of enrollment in an investigator-initiated Phase II...

Shanghai, China, August 14, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that the U.S. Food and Drug Administration...

SHANGHAI, China, July 1, 2026 Abbisko Therapeutics and AstraZeneca have entered into a strategic collaboration to advance the clinical...

ATLANTA, United States, April 7, 2026 Alzamend Neuro, Inc. announced encouraging pharmacodynamic data from its Phase II clinical trial...

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

SOUTH SAN FRANCISCO, California – March 6, 2026 Genentech announced positive topline results from the Phase II ZUPREME-1 clinical...

HONG KONG, Jan. 5, 2026 — Ascletis Pharma Inc. announced that it has received Investigational New Drug (IND) clearance...

BEIJING, China — December 23, 2025 — InnoCare Pharma has announced a major clinical development milestone with the approval...